<DOC>
	<DOCNO>NCT01963403</DOCNO>
	<brief_summary>This double-blinded , placebo-controlled , randomized trial compare effect use combined oral contraceptive pill placebo pill woman experience irregular and/or heavy bleeding associate use etonogestrel ( ETG ) implant . The hypothesis study : - Use combined oral contraceptive significantly improve bleed pattern user ETG implant - Continuation rate ETG implant user increase use combined oral contraceptive woman desire ETG implant removal undesirable bleed - Adverse event uncommon acceptable woman use combined oral contraceptive ETG implant</brief_summary>
	<brief_title>Treatment Unacceptable Bleeding Patterns ETG Implant Users With Oral Contraceptive</brief_title>
	<detailed_description>Women experience irregular and/or heavy bleeding associate use etonogestrel ( ETG ) implant recruit study . Women bothersome bleed randomize use either combined oral contraceptive pill placebo pill . Participants take one pill every day record bleeding pattern daily diary . Participants one screening/enrollment visit , two in-person follow visit , one telephone follow contact . Subjects enrol total 84 day ( three month ) . Participants assign treatment group screening/enrollment visit . Her first follow visit occur 22-28 day enrollment . Participants choose : - Continue use assign treatment medication - Discontinue use assign treatment medication , use open-label combined oral contraceptive pill - Discontinue use assign treatment medication , decline use open-label combined oral contraceptive pill - Discontinue use ETG implant . Participants choose continue use ETG implant follow telephone contact 50-56 day enrollment visit . A final in-person visit occur 78-84 day enrollment . Bleeding pattern assess daily bleed diary complete participant .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Women ETG implant place Women subjectively experience side effect undesirable bleeding profile bleed irregularity heavy flow ETG implant place desire intervention side effect either treatment bleed removal implant Age 14 year old , inclusive Irregular heavy bleed etiology ETG use ( e.g . fibroid , cervical polyp , organic cause bleeding ) Has attempt prescription treatment menstrual side effect use ETG implant Has one condition consider Category 3 ( risk outweigh benefit ) Category 4 ( unacceptable health risk ) estrogencontaining oral contraceptive Center Disease Control Medical Eligibility Criteria Contraceptive Use : Current history heart vascular disease , include deep venous thrombosis , pulmonary embolism , know thrombogenic mutation , peripartum cardiomyopathy , complicate valvular heart disease Hypertension , even adequately control Diabetes vascular involvement Headaches focal aura , migraine woman age 35 old even without focal aura Major surgery prolong immobilization Breast cancer ( current past ) Severe ( decompensated ) cirrhosis Acute flare viral hepatitis Breastfeeding le 1 month postpartum Postpartum le 3 week 35 year age old smoking Multiple risk factor arterial cardiovascular disease Systemic Lupus Erythematosus positive unknown antiphospholipid antibody Current symptomatic gallbladder disease history cholestasis relate past combined oral contraceptive use On certain anticonvulsant ( phenytoin , carbamazepine , barbiturate , primidone , topiramate , oxcarbazepine , lamotrigine ) On Ritonavirboosted protease inhibitor antiretroviral therapy Issues concern , judgment investigator , may compromise safety subject , impact subject 's adherence protocol requirement , confound reliability data acquire study</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>etonogestrel implant</keyword>
	<keyword>birth control</keyword>
	<keyword>irregular bleeding</keyword>
	<keyword>heavy bleeding</keyword>
</DOC>